Accendra Health Gross Margin 2012-2025 | ACH
Current and historical gross margin for Accendra Health (ACH) over the last 10 years. The current gross profit margin for Accendra Health as of September 30, 2025 is %.
| Accendra Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $10.75B | $2.21B | 20.55% |
| 2025-06-30 | $10.74B | $2.22B | 20.66% |
| 2025-03-31 | $10.72B | $2.21B | 20.62% |
| 2024-12-31 | $10.70B | $2.22B | 20.75% |
| 2024-09-30 | $6.62B | $1.75B | 26.51% |
| 2024-06-30 | $8.52B | $1.96B | 23.00% |
| 2024-03-31 | $10.42B | $2.16B | 20.75% |
| 2023-12-31 | $10.33B | $2.12B | 20.55% |
| 2023-09-30 | $10.23B | $1.96B | 19.17% |
| 2023-06-30 | $10.13B | $1.94B | 19.10% |
| 2023-03-31 | $10.07B | $1.95B | 19.36% |
| 2022-12-31 | $9.96B | $1.83B | 18.34% |
| 2022-09-30 | $9.87B | $1.76B | 17.84% |
| 2022-06-30 | $9.88B | $1.58B | 15.97% |
| 2022-03-31 | $9.87B | $1.44B | 14.64% |
| 2021-12-31 | $9.79B | $1.51B | 15.47% |
| 2021-09-30 | $9.68B | $1.57B | 16.23% |
| 2021-06-30 | $9.37B | $1.59B | 16.93% |
| 2021-03-31 | $8.69B | $1.46B | 16.75% |
| 2020-12-31 | $8.48B | $1.28B | 15.10% |
| 2020-09-30 | $8.31B | $1.17B | 14.04% |
| 2020-06-30 | $8.42B | $1.10B | 13.12% |
| 2020-03-31 | $8.98B | $1.12B | 12.49% |
| 2019-12-31 | $9.21B | $1.13B | 12.27% |
| 2019-09-30 | $9.14B | $0.91B | 9.99% |
| 2019-06-30 | $9.32B | $0.99B | 10.57% |
| 2019-03-31 | $9.40B | $1.02B | 10.89% |
| 2018-12-31 | $9.42B | $1.07B | 11.37% |
| 2018-09-30 | $9.69B | $1.32B | 13.61% |
| 2018-06-30 | $9.56B | $1.27B | 13.26% |
| 2018-03-31 | $9.36B | $1.22B | 12.99% |
| 2017-12-31 | $9.32B | $1.17B | 12.58% |
| 2017-09-30 | $9.30B | $1.15B | 12.39% |
| 2017-06-30 | $9.38B | $1.15B | 12.22% |
| 2017-03-31 | $9.60B | $1.17B | 12.20% |
| 2016-12-31 | $9.72B | $1.19B | 12.21% |
| 2016-09-30 | $9.84B | $1.20B | 12.23% |
| 2016-06-30 | $9.90B | $1.21B | 12.26% |
| 2016-03-31 | $9.84B | $1.21B | 12.33% |
| 2015-12-31 | $9.77B | $1.21B | 12.42% |
| 2015-09-30 | $9.78B | $1.22B | 12.44% |
| 2015-06-30 | $9.69B | $1.20B | 12.40% |
| 2015-03-31 | $9.58B | $1.19B | 12.39% |
| 2014-12-31 | $9.44B | $1.17B | 12.38% |
| 2014-09-30 | $9.27B | $1.15B | 12.37% |
| 2014-06-30 | $9.15B | $1.13B | 12.31% |
| 2014-03-31 | $9.08B | $1.12B | 12.31% |
| 2013-12-31 | $9.07B | $1.12B | 12.30% |
| 2013-09-30 | $9.04B | $1.10B | 12.13% |
| 2013-06-30 | $8.95B | $1.05B | 11.75% |
| 2013-03-31 | $8.90B | $0.99B | 11.12% |
| 2012-12-31 | $8.87B | $0.92B | 10.42% |
| 2012-09-30 | $8.78B | $0.87B | 9.88% |
| 2012-06-30 | $8.78B | $0.86B | 9.75% |
| 2012-03-31 | $8.72B | $0.86B | 9.87% |
| 2011-12-31 | $8.63B | $0.86B | 9.94% |
| 2011-09-30 | $8.50B | $0.85B | 10.02% |
| 2011-06-30 | $8.39B | $0.84B | 10.00% |
| 2011-03-31 | $8.28B | $0.82B | 9.93% |
| 2010-12-31 | $8.12B | $0.81B | 9.95% |
| 2010-09-30 | $8.09B | $0.83B | 10.24% |
| 2010-06-30 | $8.07B | $0.83B | 10.28% |
| 2010-03-31 | $8.06B | $0.83B | 10.27% |
| 2009-12-31 | $8.04B | $0.82B | 10.14% |
| 2009-09-30 | $7.96B | $0.80B | 10.09% |
| 2009-06-30 | $7.71B | $0.78B | 10.09% |
| 2009-03-31 | $7.47B | $0.76B | 10.11% |
| 2008-12-31 | $7.24B | $0.74B | 10.23% |
| 2008-09-30 | $6.93B | $0.64B | 9.30% |
| 2008-06-30 | $6.83B | $0.64B | 9.42% |
| 2008-03-31 | $6.74B | $0.65B | 9.58% |
| 2007-12-31 | $6.70B | $0.65B | 9.71% |
| 2007-09-30 | $6.61B | $0.65B | 9.79% |
| 2007-06-30 | $6.24B | $0.61B | 9.82% |
| 2007-03-31 | $5.87B | $0.58B | 9.84% |
| 2006-12-31 | $5.44B | $0.54B | 9.89% |
| 2006-09-30 | $5.10B | $0.55B | 10.83% |
| 2006-06-30 | $4.98B | $0.54B | 10.82% |
| 2006-03-31 | $4.89B | $0.53B | 10.77% |
| 2005-12-31 | $4.82B | $0.52B | 10.72% |
| 2005-09-30 | $4.77B | $0.51B | 10.60% |
| 2005-06-30 | $4.70B | $0.49B | 10.42% |
| 2005-03-31 | $4.61B | $0.48B | 10.32% |
| 2004-12-31 | $4.52B | $0.46B | 10.26% |
| 2004-09-30 | $4.47B | $0.46B | 10.19% |
| 2004-06-30 | $4.40B | $0.45B | 10.21% |
| 2004-03-31 | $4.33B | $0.44B | 10.22% |
| 2003-12-31 | $4.25B | $0.44B | 10.27% |
| 2003-09-30 | $4.16B | $0.43B | 10.37% |
| 2003-06-30 | $4.09B | $0.43B | 10.45% |
| 2003-03-31 | $4.01B | $0.42B | 10.50% |
| 2002-12-31 | $3.96B | $0.42B | 10.53% |
| 2002-09-30 | $3.91B | $0.42B | 10.67% |
| 2002-06-30 | $3.88B | $0.42B | 10.68% |
| 2002-03-31 | $3.86B | $0.41B | 10.71% |
| 2001-12-31 | $3.82B | $0.41B | 10.72% |
| 2001-09-30 | $3.74B | $0.40B | 10.71% |
| 2001-06-30 | $3.65B | $0.39B | 10.71% |
| 2001-03-31 | $3.57B | $0.38B | 10.73% |
| 2000-12-31 | $3.50B | $0.38B | 10.73% |
| 2000-09-30 | $3.47B | $0.37B | 10.61% |
| 2000-06-30 | $3.41B | $0.36B | 10.57% |
| 2000-03-31 | $3.30B | $0.35B | 10.51% |
| 1999-12-31 | $3.19B | $0.33B | 10.48% |
| 1999-09-30 | $3.04B | $0.33B | 10.68% |
| 1999-06-30 | $3.00B | $0.32B | 10.71% |
| 1999-03-31 | $3.03B | $0.32B | 10.71% |
| 1998-12-31 | $3.08B | $0.33B | 10.61% |
| 1998-09-30 | $3.17B | $0.33B | 10.44% |
| 1998-06-30 | $3.19B | $0.33B | 10.32% |
| 1998-03-31 | $3.17B | $0.32B | 10.23% |
| 1997-12-31 | $3.12B | $0.32B | 10.17% |
| 1997-09-30 | $3.07B | $0.31B | 10.01% |
| 1997-06-30 | $3.03B | $0.30B | 9.98% |
| 1997-03-31 | $3.00B | $0.30B | 9.97% |
| 1996-12-31 | $3.02B | $0.30B | 9.87% |
| 1996-09-30 | $3.01B | $0.29B | 9.53% |
| 1996-06-30 | $3.01B | $0.27B | 9.05% |
| 1996-03-31 | $3.00B | $0.27B | 8.93% |
| 1995-12-31 | $2.98B | $0.27B | 9.00% |
| 1995-09-30 | $2.96B | $0.27B | 9.26% |
| 1995-06-30 | $2.91B | $0.28B | 9.64% |
| 1995-03-31 | $2.75B | $0.27B | 9.70% |
| 1994-12-31 | $2.40B | $0.23B | 9.68% |
| 1994-09-30 | $2.04B | $0.20B | 9.55% |
| 1994-06-30 | $1.71B | $0.17B | 9.76% |
| 1994-03-31 | $1.47B | $0.15B | 9.93% |
| 1993-12-31 | $1.40B | $0.15B | 10.59% |
| 1993-09-30 | $1.33B | $0.15B | 11.39% |
| 1993-06-30 | $1.26B | $0.14B | 11.39% |
| 1993-03-31 | $1.21B | $0.14B | 11.38% |
| 1992-12-31 | $1.18B | $0.13B | 10.69% |
| 1992-09-30 | $0.93B | $0.10B | 11.22% |
| 1992-06-30 | $0.96B | $0.10B | 10.82% |
| 1992-03-31 | $0.99B | $0.10B | 10.37% |
| 1991-12-31 | $1.02B | $0.10B | 9.98% |
| 1991-09-30 | $1.00B | $0.10B | 9.94% |
| 1991-06-30 | $0.97B | $0.10B | 9.88% |
| 1991-03-31 | $0.95B | $0.09B | 9.88% |
| 1990-12-31 | $0.93B | $0.09B | 9.88% |
| 1990-09-30 | $0.95B | $0.09B | 9.48% |
| 1990-06-30 | $0.90B | $0.09B | 9.56% |
| 1990-03-31 | $0.82B | $0.08B | 9.54% |
| 1989-12-31 | $0.72B | $0.07B | 9.71% |
| 1989-09-30 | $0.87B | $0.08B | 9.35% |
| 1989-06-30 | $0.79B | $0.08B | 9.47% |
| 1989-03-31 | $0.75B | $0.07B | 9.73% |
| 1988-12-31 | $0.73B | $0.07B | 9.84% |
| 1988-09-30 | $0.70B | $0.07B | 9.73% |
| 1988-06-30 | $0.66B | $0.07B | 9.86% |
| 1988-03-31 | $0.62B | $0.06B | 9.95% |
| 1987-12-31 | $0.58B | $0.06B | 10.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.185B | $10.701B |
| Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |